AHA comments on the Health Resources and Services Administrations interim final rule that would further delay the effective date for the implementation of the Affordable Care Act provision requiring a 340B Drug Pricing Program ceiling price calculation methodology and application of civil monetary penalties for violations of the ceiling price.
Contact Your Senator on HELP Committee and Urge Them Not to Include 340B Provisions as Part of Legislative Package
The Senate Committee on Health, Education, Labor and Pensions has released the Lower Health Care Costs Act of 2019 – bipartisan discussion draft legislation to…
Joint Status Report and Stipulation of Dismissal Re: 340B Delayed Regulations on Transparency and CMPs
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
The AHA is pleased that, in response to our successful lawsuit, the Health Resources and Services Administration today launched a new website to shine needed…